Indeed, in this study we also found that APOE4 is associated with prevalence of AD-tau pathology as well as worsen amyloid score in our cohort composed of cognitively unimpaired individuals, individuals with mild cognitive impairment, and AD cases. This evidence concerns the gene MAPT and Alzheimer disease.